<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1262" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1262/" /><meta name="ncbi_pagename" content="GNE-Related Myopathy - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>GNE-Related Myopathy - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="GNE-Related Myopathy" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/03/07" /><meta name="citation_author" content="Erin K O'Ferrall" /><meta name="citation_author" content="Michael Sinnreich" /><meta name="citation_pmid" content="20301439" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1262/" /><meta name="citation_keywords" content="Distal Myopathy with Rimmed Vacuoles (DMRV)" /><meta name="citation_keywords" content="Hereditary Inclusion Body Myopathy 2 (HIBM)" /><meta name="citation_keywords" content="Nonaka Myopathy" /><meta name="citation_keywords" content="Distal Myopathy with Rimmed Vacuoles" /><meta name="citation_keywords" content="Hereditary Inclusion Body Myopathy 2" /><meta name="citation_keywords" content="Nonaka Myopathy" /><meta name="citation_keywords" content="DMRV" /><meta name="citation_keywords" content="HIBM" /><meta name="citation_keywords" content="Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase" /><meta name="citation_keywords" content="GNE" /><meta name="citation_keywords" content="GNE-Related Myopathy" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="GNE-Related Myopathy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Erin K O'Ferrall" /><meta name="DC.Contributor" content="Michael Sinnreich" /><meta name="DC.Date" content="2013/03/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1262/" /><meta name="description" content="GNE-related myopathy, also known as inclusion body myopathy 2, is characterized by slowly progressive distal muscle weakness that begins in the late teens to early adult years with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier." /><meta name="og:title" content="GNE-Related Myopathy" /><meta name="og:type" content="book" /><meta name="og:description" content="GNE-related myopathy, also known as inclusion body myopathy 2, is characterized by slowly progressive distal muscle weakness that begins in the late teens to early adult years with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1262/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/ibm/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1262/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B7DF5E040E02100000000001E0009.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1262_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1262_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/glyt1-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ml2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1262_"><span class="title" itemprop="name"><i>GNE</i>-Related Myopathy</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Distal Myopathy with Rimmed Vacuoles (DMRV), Hereditary Inclusion Body Myopathy 2 (HIBM), Nonaka Myopathy</div><p class="contrib-group"><span itemprop="author">Erin K O'Ferrall</span>, MD, MSc, FRCPC and <span itemprop="author">Michael Sinnreich</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1262_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1262_ai__"><div class="contrib half_rhythm"><span itemprop="author">Erin K O'Ferrall</span>, MD, MSc, FRCPC<div class="affiliation small">Neuromuscular Research Department<br />Montreal Neurological Institute<br />Montreal, Quebec<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lligcm@llarrefo.nire" class="oemail">ac.lligcm@llarrefo.nire</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Michael Sinnreich</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Neuromuscular Center<br />University Hospital Basel<br />Basel, Switzerland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@hciernnis_leahcim" class="oemail">moc.liamtoh@hciernnis_leahcim</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 26, 2004</span>; Last Update: <span itemprop="dateModified">March 7, 2013</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ibm.Summary" itemprop="description"><h2 id="_ibm_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>GNE</i>-related myopathy, also known as inclusion body myopathy 2, is characterized by slowly progressive distal muscle weakness that begins in the late teens to early adult years with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>GNE</i>-related myopathy is based on clinical and histopathologic criteria. Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) are common, the presence of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relatives is not obligatory for the diagnosis. Muscle histopathology typically shows rimmed vacuoles and characteristic filamentous inclusions. <i>GNE</i>, which encodes the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause <i>GNE</i>-related myopathy.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic. Individuals are often evaluated and managed by a multidisciplinary team including neurologists, geneticists and physiatrists, as well as physical and occupational therapists. All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should consult their physician before beginning an exercise program.</p><p><i>Surveillance:</i> Annual routine follow up with the multidisciplinary team, including screening for signs and symptoms of cardiac and respiratory dysfunction.</p><p><i>Agents/circumstances to avoid</i>: Medications/drugs with potential myotoxicity should be used with caution.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>GNE</i>-related myopathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk family members and prenatal testing for a pregnancy at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="ibm.Diagnosis"><h2 id="_ibm_Diagnosis_">Diagnosis</h2><div id="ibm.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The following clinical diagnostic criteria for <i>GNE</i>-related myopathy have been proposed [<a class="bk_pop" href="#ibm.REF.griggs.1995.705">Griggs et al 1995</a>, <a class="bk_pop" href="#ibm.REF.argov.2003.1519">Argov et al 2003</a>]:</p><ul><li class="half_rhythm"><div>A primary skeletal muscle disease, usually presenting with weakness in the legs</div></li><li class="half_rhythm"><div>Sustained quadriceps sparing despite marked weakness of all other proximal lower-extremity muscles</div></li><li class="half_rhythm"><div>Onset in late teenage years or early adulthood</div></li><li class="half_rhythm"><div>Modest elevation of serum creatine kinase activity, between two and four times the normal value</div></li><li class="half_rhythm"><div>Muscle biopsy</div><ul><li class="half_rhythm"><div class="half_rhythm">On cryostat sections, the most prominent finding is the presence of rimmed vacuoles, lined by basophilic granular material on H&#x00026;E staining and purple-red in color with the modified Gomori trichrome stain. The vacuoles themselves do not stain with oil red orange or PAS stains, and lack acid phosphatase activity; however, with the latter, a few vacuoles show faint activity in the periphery. The vacuoles either appear empty or contain granular or amorphous basophilic inclusions or congophilic masses. Fiber size varies, with both atrophic and hypertrophic fibers observed. Endomysial fibrosis may be considerable. Many fibers contain internal myonuclei and fiber splitting occurs [<a class="bk_pop" href="#ibm.REF.mizusawa.1987.129">Mizusawa et al 1987</a>, <a class="bk_pop" href="#ibm.REF.sadeh.1993.217">Sadeh et al 1993</a>].</div><div class="half_rhythm">Note: The origin of the rimmed vacuoles and their contents remains controversial. It has been suggested that they may be autophagic in nature, but the lack of acid phosphatase activity argues against this suggestion. Some authors have suggested that they arise from the membranous structures of the cell (SR, T-tubules, Golgi). Others have suggested that they arise when myonuclei burst and discharge their basophilic content into the cytoplasm [<a class="bk_pop" href="#ibm.REF.griggs.1995.705">Griggs et al 1995</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">On ultrastructural analysis, the vacuoles do not appear as empty spaces but are filled with membranous whorls and cytoplasmic debris. Certain fibers harbor cytoplasmic or nuclear tubulo-filamentous inclusions with a diameter of 16-18 nm.</div></li><li class="half_rhythm"><div class="half_rhythm">In general, inflammation is not observed in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> muscle. However, a modest inflammatory response has been noted in a few individuals [<a class="bk_pop" href="#ibm.REF.argov.2003.1519">Argov et al 2003</a>, <a class="bk_pop" href="#ibm.REF.krause.2003.830">Krause et al 2003</a>, <a class="bk_pop" href="#ibm.REF.yabe.2003.384">Yabe et al 2003</a>] and inflammatory cell invasion of non-necrotic muscle fibers is rarely reported [<a class="bk_pop" href="#ibm.REF.krause.2003.830">Krause et al 2003</a>].</div></li></ul></li><li class="half_rhythm"><div>Early changes in certain muscle groups (before clinical weakness is detected) visualized by the following [<a class="bk_pop" href="#ibm.REF.mizusawa.1987.129">Mizusawa et al 1987</a>, <a class="bk_pop" href="#ibm.REF.sadeh.1993.217">Sadeh et al 1993</a>]:</div><ul><li class="half_rhythm"><div>Electromyogram showing myopathic motor unit potentials in association with spontaneous activity, similar to the pattern seen in inflammatory myopathies</div></li><li class="half_rhythm"><div>CT or MRI examination of muscle showing fatty replacement of muscle</div></li></ul></li><li class="half_rhythm"><div>Normal nerve conduction velocity studies</div></li></ul><p>Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases are common, presence of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relatives is not obligatory for the diagnosis.</p></div><div id="ibm.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><i>GNE</i>, encoding UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause <i>GNE</i>-related myopathy [<a class="bk_pop" href="#ibm.REF.eisenberg.2001.83">Eisenberg et al 2001</a>].</p><div id="ibm.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>GNE</i>-Related Myopathy</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1262/table/ibm.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ibm.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Method&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GNE</i></td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figibmTselectedgnepathogenicvariants" rid-ob="figobibmTselectedgnepathogenicvariants">p.Met712Thr</a></td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Middle Eastern Jewish population ~100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence / variant scanning analysis&#x000a0;<sup>5,</sup>&#x000a0;<sup>6</sup></td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60%-80%&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing&#x000a0;<sup>8</sup></td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions&#x000a0;<sup>9</sup></td><td headers="hd_h_ibm.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="ibm.TF.1.1"><p class="no_margin">See <a href="/books/NBK1262/#ibm.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="ibm.TF.1.2"><p class="no_margin">See <a href="#ibm.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="ibm.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="ibm.TF.1.4"><p class="no_margin">The <a class="figpopup" href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figibmTselectedgnepathogenicvariants" rid-ob="figobibmTselectedgnepathogenicvariants">p.Met712Thr</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is predominant in Middle Eastern Jewish individuals but has also been identified in a small number of non-Jewish families [<a class="bk_pop" href="#ibm.REF.eisenberg.2003.99">Eisenberg et al 2003</a>].</p></div></dd><dt>5. </dt><dd><div id="ibm.TF.1.5"><p class="no_margin">Sequence analysis and scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for pathogenic variants can have similar variant detection frequencies; however, variant detection rates for scanning may vary considerably between laboratories depending on the specific protocol used.</p></div></dd><dt>6. </dt><dd><div id="ibm.TF.1.6"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>7. </dt><dd><div id="ibm.TF.1.7"><p class="no_margin">Detection rate varies by certainty of clinical diagnosis.</p></div></dd><dt>8. </dt><dd><div id="ibm.TF.1.8"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>9. </dt><dd><div id="ibm.TF.1.9"><p class="no_margin">A large <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> involving exons 1 to 9 has also been reported [<a class="bk_pop" href="#ibm.REF.del_bo.2003.113">Del Bo et al 2003</a>]. The frequency and detection rates are not known.</p></div></dd></dl></div></div></div></div><div id="ibm.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Convenient and cost-effective diagnostic algorithm:</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">History to determine age of onset, pattern of muscle weakness, and progression over time; physical examination with particular attention to quadriceps sparing</p></dd><dt>2.</dt><dd><p class="no_top_margin">Family history and examination of suspected members</p></dd><dt>3.</dt><dd><p class="no_top_margin">Electromyogram to help identify the pattern of muscle involvement</p></dd><dt>4.</dt><dd><p class="no_top_margin">Serum creatine kinase activity</p></dd></dl><p>In an individual with one or more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members who presents with the typical clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., distal-onset weakness in early adulthood with progressive, symmetric leg weakness sparing the quadriceps), the following testing should be considered:</p><ul><li class="half_rhythm"><div>Sequence analysis of <i>GNE</i> (muscle biopsy not required in this case)</div></li><li class="half_rhythm"><div>In individuals of Middle Eastern Jewish descent, <a class="def" href="/books/n/gene/glossary/def-item/targeted-analysis-for-pathogenic-variants/">targeted analysis for pathogenic variants</a> may be performed first, followed by full <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> sequencing if two pathogenic variants are not found.</div></li><li class="half_rhythm"><div>Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing can be considered if the above tests are normal</div></li></ul><p>In individuals with no known family history of muscle disease and/or an atypical clinical presentation (such as sparing of the quadriceps), the following testing algorithm should be considered:</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Perform muscle biopsy.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If the muscle biopsy demonstrates typical findings of <i>GNE</i>-related myopathy, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>GNE</i> can then be pursued.</p></dd></dl><p>Muscle biopsy may be useful in two additional scenarios:</p><ul><li class="half_rhythm"><div class="half_rhythm">In individuals where genetic testing has revealed previously unreported <i>GNE</i> variants of unknown pathogenicity, muscle biopsy may be helpful. If the typical myopathology of <i>GNE</i>-related myopathy is demonstrated by the muscle biopsy, this would support the pathogenicity of the <i>GNE</i> variant.</div><div class="half_rhythm">In individuals with previously unreported <i>GNE</i> variants of unknown pathogenicity, analysis of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase enzyme activity in lymphocytes may also be helpful.</div></li><li class="half_rhythm"><div class="half_rhythm">Muscle biopsy is important in any individual with recent onset of weakness to exclude a treatable inflammatory myopathy.</div></li></ul><p><b>Carrier testing for at-risk relatives</b> requires prior identification of pathogenic variants in the family.</p><p>Note: Carriers are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder and are not at risk of developing the disorder.</p><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the pathogenic variants in the family.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p></div></div><div id="ibm.Clinical_Characteristics"><h2 id="_ibm_Clinical_Characteristics_">Clinical Characteristics</h2><div id="ibm.Clinical_Description"><h3>Clinical Description</h3><p>Weakness starts in young adulthood, usually in the second part of the third decade, with a predilection for distal limb muscles. The initial symptom is difficulty with gait as a result of foot drop secondary to anterior tibialis muscle weakness. The weakness spreads and within several years involves thigh and hand muscles. Shoulder girdle muscles are weak, with relative sparing of the triceps. Neck flexors are commonly involved.</p><p>The striking feature is quadriceps sparing even at advanced stages of the disease. However, based on results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, it is now recognized that quadriceps sparing is not a constant feature; some individuals without this finding have been identified [<a class="bk_pop" href="#ibm.REF.argov.2003.1519">Argov et al 2003</a>].</p><p>Affected individuals are usually wheelchair bound about 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier.</p><p>Ocular, pharyngeal, and cardiac muscles are usually spared. A single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been described with respiratory involvement resulting in a reduced FEV1 (forced expiratory volume in 1 second) and vital capacity [<a class="bk_pop" href="#ibm.REF.weihl.2011.102">Weihl et al 2011</a>].</p><p>Occasionally, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have facial weakness [<a class="bk_pop" href="#ibm.REF.argov.1998.1925">Argov et al 1998</a>].</p><p>Intellectual abilities are unaffected. The impact of <i>GNE</i>-related myopathy on life expectancy for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with modern multidisciplinary medical care is unclear.</p></div><div id="ibm.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date, more than 60 pathogenic variants in <i>GNE</i> have been described [reviewed in <a class="bk_pop" href="#ibm.REF.huizing.2009.881">Huizing &#x00026; Krasnewich 2009</a>]. Because reports of individuals with <i>GNE</i>-related myopathy consist mainly of single case reports or relatively small case series, correlations between <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are difficult. However, a recent study of 71 Japanese individuals with <i>GNE</i>-related myopathy has suggested that those harboring a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<a class="figpopup" href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figibmTselectedgnepathogenicvariants" rid-ob="figobibmTselectedgnepathogenicvariants">p.Val572Leu</a>) in the N-acetylmannosamine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> have an earlier disease onset than those who are compound heterozygotes for pathogenic variants in the epimerase and kinase domains [<a class="bk_pop" href="#ibm.REF.moriyoshimura.2012.100">Mori-Yoshimura et al 2012</a>]. The individuals with two kinase domain pathogenic variants were also more frequently nonambulatory. These findings need to be confirmed in other populations.</p></div><div id="ibm.Penetrance"><h3>Penetrance</h3><p>Penetrance is probably not 100%; three individuals with two pathogenic variants were asymptomatic at advanced age. Two were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> [<a class="bk_pop" href="#ibm.REF.argov.2003.1519">Argov et al 2003</a>] and one was <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> [<a class="bk_pop" href="#ibm.REF.nishino.2002.1689">Nishino et al 2002</a>].</p></div><div id="ibm.Nomenclature"><h3>Nomenclature</h3><p>The entity of hereditary inclusion body myopathy 2 (h-IBM2) was likely first recognized in Japan. In 1981, Nonaka and coworkers described an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> distal myopathy with rimmed vacuoles (DMRV) in the Western literature [<a class="bk_pop" href="#ibm.REF.nonaka.1981.141">Nonaka et al 1981</a>, <a class="bk_pop" href="#ibm.REF.sunohara.1989.65">Sunohara et al 1989</a>]; they give credit to <a class="bk_pop" href="#ibm.REF.sasaki.1969.627">Sasaki et al [1969]</a> and <a class="bk_pop" href="#ibm.REF.ideta.1973.579">Ideta et al [1973]</a> for having previously described in the Japanese literature possibly similar cases.</p><p><a class="bk_pop" href="#ibm.REF.argov.1984.33">Argov &#x00026; Yarom [1984]</a> published nine cases from four Jewish families of Iranian descent of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> "rimmed vacuole myopathy" sparing the quadriceps. A larger series of Iranian Jewish individuals with the same disorder was subsequently published by a group from Tel Aviv [<a class="bk_pop" href="#ibm.REF.sadeh.1993.217">Sadeh et al 1993</a>]. The disorder was characterized by progressive distal and proximal weakness and wasting beginning in the legs and sparing the quadriceps, even in advanced stages. The disease was subsequently found in other ethnic groups [<a class="bk_pop" href="#ibm.REF.sivakumar.1996.977">Sivakumar &#x00026; Dalakas 1996</a>]; with the identification of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative [<a class="bk_pop" href="#ibm.REF.eisenberg.2001.83">Eisenberg et al 2001</a>], it became apparent that the disorder was the same disease as DMRV [<a class="bk_pop" href="#ibm.REF.nishino.2002.1689">Nishino et al 2002</a>].</p></div><div id="ibm.Prevalence"><h3>Prevalence</h3><p>To date, more than 200 individuals with <i>GNE</i>-related myopathy have been described: about 160 of Iranian Jewish descent with the <a class="figpopup" href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figibmTselectedgnepathogenicvariants" rid-ob="figobibmTselectedgnepathogenicvariants">p.Met712Thr</a> <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a>, 15 Japanese individuals with the <a class="figpopup" href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figibmTselectedgnepathogenicvariants" rid-ob="figobibmTselectedgnepathogenicvariants">p.Val572Leu</a> founder variant, and the remainder with more than 60 pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pattern [<a class="bk_pop" href="#ibm.REF.huizing.2009.881">Huizing &#x00026; Krasnewich 2009</a>].</p><p>In Israel random testing of 75 Iranian Jewish individuals, unrelated to individuals with IBM, identified five carriers [<a class="bk_pop" href="#ibm.REF.eisenberg.2001.83">Eisenberg et al 2001</a>].</p><p>Considering a worldwide Iranian Jewish population of 150,000-300,000 reported by the Iranian Jewish society in Los Angeles and Israel, prevalence rate appears to be between 1:500 and 1:1,000 in Iranian Jews.</p><p>Individuals with <i>GNE</i>-related myopathy have been reported in Tunisia [<a class="bk_pop" href="#ibm.REF.amouri.2005.361">Amouri et al 2005</a>] and Italy [<a class="bk_pop" href="#ibm.REF.broccolini.2004.632">Broccolini et al 2004</a>]. Pathogenic variants in <i>GNE</i> have been reported worldwide.</p></div></div><div id="ibm.Genetically_Related_Allelic_Disorder"><h2 id="_ibm_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Pathogenic variants in <i>GNE</i> also cause sialuria (OMIM <a href="http://omim.org/entry/269921" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">269921</a>). In this disorder, the pathogenic variants occur at the allosteric site of the epimerase, abolishing the feedback inhibition mechanism by CMP-sialic acid that results in overproduction of sialic acid [<a class="bk_pop" href="#ibm.REF.seppala.1999.1563">Seppala et al 1999</a>]. Affected individuals exhibit variable degrees of developmental delay, coarse facial features, and hepatomegaly. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p></div><div id="ibm.Differential_Diagnosis"><h2 id="_ibm_Differential_Diagnosis_">Differential Diagnosis</h2><p>Several forms of hereditary inclusion body myopathy (IBM) have been described under various names, each with its own clinical characteristics and ethnic clustering (see <a class="figpopup" href="/books/NBK1262/table/ibm.T.distal_myopathies/?report=objectonly" target="object" rid-figpopup="figibmTdistalmyopathies" rid-ob="figobibmTdistalmyopathies">Table 2</a>):</p><ul><li class="half_rhythm"><div><b>Inclusion body myopathy 3</b> (IBM3) (OMIM <a href="http://omim.org/entry/605637" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">605637</a>), reported in a Swedish family, caused by a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant in the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the myosin heavy chain IIa (<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17p) [<a class="bk_pop" href="#ibm.REF.martinsson.2000.14614">Martinsson et al 2000</a>]</div></li><li class="half_rhythm"><div><a href="/books/n/gene/ibmpfd/"><b>Inclusion body myopathy associated with Paget disease of the bone and/or frontotemporal dementia</b></a><b>, or IBMPFD,</b> characterized by adult-onset proximal and distal muscle weakness (clinically resembling a limb-girdle muscular dystrophy syndrome), early-onset Paget disease of the bone (PDB), and premature frontotemporal dementia (FTD). Muscle weakness progresses to involve other limb and respiratory muscles. Cardiac failure and cardiomyopathy have been observed in later stages. PDB involves focal areas of increased bone turnover that typically lead to spine and/or hip pain and localized enlargement and deformity of the long bones; pathologic fractures occasionally occur. Early stages of FTD are characterized by dysnomia, dyscalculia, comprehension deficits, paraphasic errors, and relative preservation of memory; and later stages by inability to speak, auditory comprehension deficits for even one-step commands, alexia, and agraphia. Mean age at diagnosis for muscle disease and PDB is 42 years; for FTD, 55 years. <i>VCP</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause IBMPFD. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div><b>Autosomal dominant limb-girdle muscular dystrophy type 1A</b> (LGMD1A, OMIM <a href="http://omim.org/entry/159000" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">159000</a>), which presents with rimmed vacuoles on histologic examination and is caused by pathogenic variants in the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding myotilin [<a class="bk_pop" href="#ibm.REF.hauser.2000.2141">Hauser et al 2000</a>]</div></li><li class="half_rhythm"><div><b>Autosomal recessive limb-girdle muscular dystrophy type 2J</b> caused by pathogenic variants in <i>TTN</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding titin, may also demonstrate rimmed vacuoles [<a class="bk_pop" href="#ibm.REF.udd.2005.636">Udd et al 2005</a>].</div></li><li class="half_rhythm"><div><b>A French-Canadian <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> myopathy,</b> with changes resembling inclusion body myopathy and periventricular leukoencephalopathy [<a class="bk_pop" href="#ibm.REF.cole.1988.1025">Cole et al 1988</a>, <a class="bk_pop" href="#ibm.REF.argov.1998.1925">Argov et al 1998</a>]</div></li></ul><div id="ibm.T.distal_myopathies" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Distal Myopathies</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1262/table/ibm.T.distal_myopathies/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ibm.T.distal_myopathies_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disease Name</th><th id="hd_h_ibm.T.distal_myopathies_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mean Age at Onset (in yrs)</th><th id="hd_h_ibm.T.distal_myopathies_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Initial Muscle Group Involved</th><th id="hd_h_ibm.T.distal_myopathies_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Serum<br />Creatine<br />Kinase<br />Concentration</th><th id="hd_h_ibm.T.distal_myopathies_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle Biopsy</th><th id="hd_h_ibm.T.distal_myopathies_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene (Locus&#x000a0;<sup>1</sup>)</th></tr></thead><tbody><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1 hd_h_ibm.T.distal_myopathies_1_1_1_2 hd_h_ibm.T.distal_myopathies_1_1_1_3 hd_h_ibm.T.distal_myopathies_1_1_1_4 hd_h_ibm.T.distal_myopathies_1_1_1_5 hd_h_ibm.T.distal_myopathies_1_1_1_6" colspan="6" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Autosomal dominant</b></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Welander distal myopathy (OMIM <a href="http://omim.org/entry/604454" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604454</a>)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distal upper limbs (finger &#x00026; wrist extensors)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Normal or slightly &#x02191;</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rimmed vacuoles</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(2p13)</td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/udd/">Udd distal myopathy</a></td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;35</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Anterior compartment in legs</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; Rimmed vacuoles</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TTN</i></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Zaspopathy (Markesbery-Griggs late-onset distal myopathy)<br />(OMIM <a href="https://omim.org/entry/609452" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609452</a>)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">Vacuolar &#x00026; myofibrillar myopathy</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LDB3</i></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distal myotilinopathy<br />(OMIM <a href="https://omim.org/entry/609200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609200</a>)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;40</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior &#x0003e; anterior in legs</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Slightly &#x02191;</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vacuolar &#x00026; myofibrillar</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYOT</i></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mpd1/">Laing early-onset distal myopathy</a> (MPD1)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;20</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anterior compartment in legs &#x00026; neck flexors</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Moderately &#x02191;</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Type 1 fiber atrophy in tibial anterior muscles; disproportion in proximal muscles</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYH7</i></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distal myopathy with vocal cord and pharyngeal signs (MPD2)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35-60</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Asymmetric lower leg &#x00026; hands; dysphonia</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-8x</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rimmed vacuoles</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(5q)</td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distal myopathy with <i>pes cavus</i> and areflexia</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15-50</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anterior &#x00026; posterior lower leg; dysphonia &#x00026; dysphagia</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-6x</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystrophic, rimmed vacuoles</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(19p13)</td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">New Finnish distal myopathy (MPD3)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;30</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hands or anterior lower leg</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-4x</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dystrophic; rimmed vacuoles; eosinophilic inclusions</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(8p22-q11 &#x00026; 12q13-q22)</td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1 hd_h_ibm.T.distal_myopathies_1_1_1_2 hd_h_ibm.T.distal_myopathies_1_1_1_3 hd_h_ibm.T.distal_myopathies_1_1_1_4 hd_h_ibm.T.distal_myopathies_1_1_1_5 hd_h_ibm.T.distal_myopathies_1_1_1_6" colspan="6" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Autosomal recessive</b></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/miyoshi/">Miyoshi early-adult-onset myopathy</a></td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">19</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior compartment in legs</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;10x</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myopathic changes</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DYSF</i></td></tr><tr><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ano5-md/">Miyoshi muscular dystrophy 3</a> (MMD3)</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20-25</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior compartment in legs , asymmetry</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;10x</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myopathic changes&#x00026; (rarely) rimmed vacuoles</td><td headers="hd_h_ibm.T.distal_myopathies_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANO5</i></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Modified from <a class="bk_pop" href="#ibm.REF.udd.2001.561">Udd &#x00026; Griggs [2001]</a></p></div></dd><dt>1. </dt><dd><div id="ibm.TF.2.1"><p class="no_margin">Locus given only if <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is unknown</p></div></dd></dl></div></div></div><p><b>Myopathology.</b> Rimmed vacuoles are induced by freezing of muscle for preparation of cryostat sections. On plastic embedded semi-thin sections, corresponding areas do not appear as vacuoles but contain clusters of refractile granules, composed of membranous whorls as seen on electron microscopy. Such structures are nonspecific, as they can be found in many unrelated diseases including <a href="/books/n/gene/opmd/">oculopharyngeal muscular dystrophy</a> [<a class="bk_pop" href="#ibm.REF.abubaker.2007.173">Abu-Baker &#x00026; Rouleau 2007</a>], <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> inclusion body myositis [<a class="bk_pop" href="#ibm.REF.karpati.2009.7">Karpati &#x00026; O'Ferrall 2009</a>], zaspopathy (Markesbery-Griggs-Udd myopathy) [<a class="bk_pop" href="#ibm.REF.markesbery.1977.727">Markesbery et al 1977</a>, <a class="bk_pop" href="#ibm.REF.borg.1991.102">Borg et al 1991</a>, <a class="bk_pop" href="#ibm.REF.lindberg.1991.76">Lindberg et al 1991</a>, <a class="bk_pop" href="#ibm.REF.udd.1993.604">Udd et al 1993</a>], <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> inclusion body myopathy 3 [<a class="bk_pop" href="#ibm.REF.martinsson.2000.14614">Martinsson et al 2000</a>], LGMD2J [<a class="bk_pop" href="#ibm.REF.udd.2005.636">Udd et al 2005</a>], and LGMD 1A [<a class="bk_pop" href="#ibm.REF.hauser.2000.2141">Hauser et al 2000</a>]. They can be generated experimentally by chloroquine [<a class="bk_pop" href="#ibm.REF.macdonald.1970.479">Macdonald &#x00026; Engel 1970</a>] or vincristine [<a class="bk_pop" href="#ibm.REF.clarke.1972.247">Clarke et al 1972</a>] and are even found in chronic denervating conditions [<a class="bk_pop" href="#ibm.REF.fukuhara.1980.229">Fukuhara et al 1980</a>].</p></div><div id="ibm.Management"><h2 id="_ibm_Management_">Management</h2><div id="ibm.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>GNE</i>-related myopathy, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="ibm.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment is symptomatic only:</p><ul><li class="half_rhythm"><div>Individuals with <i>GNE</i>-related myopathy may benefit from consultation with physiatrists, physiotherapists, and occupational therapists.</div></li><li class="half_rhythm"><div>Foot drop bracing and other mechanical aids may improve the function of individuals with <i>GNE</i>-related myopathy.</div></li><li class="half_rhythm"><div>Consultation with a pulmonologist to evaluate for nocturnal hypoventilation or sleep apnea may be considered in symptomatic individuals.</div></li><li class="half_rhythm"><div>All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should consult their physician before beginning an exercise program.</div></li></ul></div><div id="ibm.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>No treatment that reverses or slows the natural history of muscle weakness in <i>GNE</i>-related myopathy is available.</p></div><div id="ibm.Surveillance"><h3>Surveillance</h3><p>Annual routine follow-up with the multidisciplinary team is recommended. Affected individuals should be screened for signs and symptoms of cardiac dysfunction, as two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> sibs with cardiomyopathy have been reported [<a class="bk_pop" href="#ibm.REF.chai.2011.133">Chai et al 2011</a>]. Affected individuals should also be evaluated for respiratory dysfunction, with appropriate investigations and treatment as needed.</p></div><div id="ibm.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>It may be prudent to use medications/drugs with potential myotoxicity (for example: colchicine) with caution.</p></div><div id="ibm.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#ibm.Related_Genetic_Counseling_Issues">Related Genetic Counseling Issues</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="ibm.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Several therapies are under investigation for <i>GNE</i>-related myopathy, including oral sialic acid or its metabolites, intravenous immune globulin, and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> replacement therapy.</p><p>Some investigators believe that the reduction of the sialylation status of glycoproteins in muscle of individuals with <i>GNE</i>-related myopathy is causative of the disease [<a class="bk_pop" href="#ibm.REF.huizing.2004.196">Huizing et al 2004</a>, <a class="bk_pop" href="#ibm.REF.noguchi.2004.11402">Noguchi et al 2004</a>, <a class="bk_pop" href="#ibm.REF.saito.2004.158">Saito et al 2004</a>]. Muscle atrophy and weakness in a mouse model of <i>GNE</i>-related myopathy are prevented by administration of sialic acid metabolites [<a class="bk_pop" href="#ibm.REF.malicdan.2009.690">Malicdan et al 2009</a>]. Several oral exogenous forms of sialic acid (e.g., sialic acid-extended release and N-acetylmannosaminic acid) are currently being investigated in clinical trials for human <i>GNE</i>-related myopathy (see <a href="http://www.clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> for details).</p><p>Intravenous immune globulin (IVIG) is a glycoprotein that can be metabolized by neuraminidase to provide free sialic acid. A single trial of IVIG in four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals resulted in mild improvement in muscle strength [<a class="bk_pop" href="#ibm.REF.sparks.2007.3">Sparks et al 2007</a>].</p><p>A single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has been treated with intramuscular injections of a GNE expression vector in a lipoplex vehicle [<a class="bk_pop" href="#ibm.REF.nemunaitis.2010.403">Nemunaitis et al 2010</a>]. The same person was later treated with intravenous infusion of the GNE-lipoplex preparation [<a class="bk_pop" href="#ibm.REF.nemunaitis.2011.1331">Nemunaitis et al 2011</a>]. No conclusions can yet be made about the efficacy of such treatment. Reported side effects of the latter treatment included low-grade fever, tachycardia, myalgia, transaminase elevation, hyponatremia, and hypotension. Further studies are required before these therapies will be available for widespread use.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="ibm.Genetic_Counseling"><h2 id="_ibm_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="ibm.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>GNE</i>-related myopathy is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="ibm.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes; therefore, each carries one of the <i>GNE</i> alleles present in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with a <i>GNE</i>-related myopathy are obligate heterozygotes (carriers) of one of the <i>GNE</i> pathogenic variants present in the proband.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each unaffected sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="ibm.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family are known.</p></div><div id="ibm.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="ibm.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>GNE</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="ibm.Resources"><h2 id="_ibm_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Advancement of Research for Myopathies (ARM)</b></div><div>P.O. Box 261926</div><div>Encino 91426-1926</div><div><b>Phone:</b> 800-ARM-2000</div><div><a href="https://hibm.org/arm/home" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hibm.org/arm</a></div></li><li class="half_rhythm"><div><b>GNE Myopathy International</b></div><div><b>Phone:</b> 91-9810881439</div><div><b>Email:</b> gne.myopathy@gmail.com</div><div><a href="http://gne-myopathy.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.gne-myopathy.org</a></div></li><li class="half_rhythm"><div><b>Neuromuscular Disease Foundation (NDF)</b></div><div><b>Phone:</b> 310-721-1605; 516-441-7126</div><div><a href="https://curehibm.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.curehibm.org</a></div></li><li class="half_rhythm"><div><b>TREAT-NMD</b></div><div>Neuromuscular Network</div><div><b>Email:</b> info@treat-nmd.eu</div><div><a href="http://www.treat-nmd.eu/gne/about/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">About GNE Myopathy</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>Myositis Association</b></div><div>1737 King Street</div><div>Suite 600</div><div>Alexandria VA 22314</div><div><b>Phone:</b> 800-821-7356 (toll-free); 703-299-4850</div><div><b>Fax:</b> 703-535-6752</div><div><b>Email:</b> tma@myositis.org</div><div><a href="http://www.myositis.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.myositis.org</a></div></li><li class="half_rhythm"><div><b>Remudy - Registry of Muscular Dystrophies</b></div><div>Japan</div><div><a href="http://www.remudy.jp/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.remudy.jp</a></div></li></ul></div><div id="ibm.Molecular_Genetics"><h2 id="_ibm_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="ibm.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>GNE-Related Myopathy: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1262/table/ibm.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ibm.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_ibm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_ibm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_ibm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_ibm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_ibm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_ibm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_ibm.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10020" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GNE</i></a></td><td headers="hd_b_ibm.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10020" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_ibm.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y223" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase</a></td><td headers="hd_b_ibm.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/GNE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNE homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_ibm.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GNE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNE</a></td><td headers="hd_b_ibm.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GNE[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GNE</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="ibm.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="ibm.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for GNE-Related Myopathy (<a href="/omim/603824,605820" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1262/table/ibm.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ibm.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603824" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603824</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; GNE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605820" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605820</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NONAKA MYOPATHY; NM</td></tr></tbody></table></div></div><div id="ibm.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase is the key enzyme in the biosynthetic pathway of sialic acids, which are the most abundant terminal monosaccharides on glycoconjugates in eukaryotic cells. The first two steps of sialic acid biosynthesis are catalyzed by each one of the two distinct functional domains of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. First, the UDP-GlcNAc 2-epimerase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> forms ManNAc from UDP-GlcNAc with simultaneous release of UDP. ManNAc is then phosphorylated at C6 by a specific kinase; subsequently, sialic acid is formed by condensation of N-acetylmannosamine-6-phosphate and phosphoenolpyruvate, and activated by CTP to form CMP-sialic acid [<a class="bk_pop" href="#ibm.REF.effertz.1999.28771">Effertz et al 1999</a>].</p><p><b>Gene structure.</b> Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of <i>GNE</i> results in transcript variants encoding different <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>. The transcript variant <a href="/nuccore/NM_005476.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005476.5</a> has 12 exons and a length of 5329 base pairs (see also Ensembl Genome Browser, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> ID <a href="http://uswest.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000159921;r=9:36214438-36277053" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ENSG00000159921</a>). For a detailed summary of gene and protein information, see <a href="/books/NBK1262/#ibm.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 60 different <i>GNE</i>-related myopathy-causing variants in <i>GNE</i> have been identified to date [reviewed in <a class="bk_pop" href="#ibm.REF.broccolini.2002.1808">Broccolini et al 2002</a>, <a class="bk_pop" href="#ibm.REF.nishino.2002.1689">Nishino et al 2002</a>, <a class="bk_pop" href="#ibm.REF.del_bo.2003.113">Del Bo et al 2003</a>, <a class="bk_pop" href="#ibm.REF.eisenberg.2003.99">Eisenberg et al 2003</a>, <a class="bk_pop" href="#ibm.REF.krause.2003.830">Krause et al 2003</a>, <a class="bk_pop" href="#ibm.REF.saito.2004.158">Saito et al 2004</a>, <a class="bk_pop" href="#ibm.REF.huizing.2009.881">Huizing &#x00026; Krasnewich 2009</a>]. Most are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants affecting either the epimerase or the kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, although <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants and deletions have also been reported. In Middle Eastern Jewish individuals, the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> p.Met712Thr variant is the only <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified to date [<a class="bk_pop" href="#ibm.REF.eisenberg.2003.99">Eisenberg et al 2003</a>], and in Japanese individuals, the homozygous p.Val572Leu variant appears to be more common [<a class="bk_pop" href="#ibm.REF.arai.2002.516">Arai et al 2002</a>], reflecting the respective founder effects. Note, however, that additional pathogenic variants, including p.Met712Thr, have been described in individuals of Japanese origin [<a class="bk_pop" href="#ibm.REF.tomimitsu.2004.1607">Tomimitsu et al 2004</a>, <a class="bk_pop" href="#ibm.REF.moriyoshimura.2012.100">Mori-Yoshimura et al 2012</a>]. (For more information, see <a href="/books/NBK1262/#ibm.molgen.TA">Table A</a>.)</p><div id="ibm.T.selected_gne_pathogenic_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Selected <i>GNE</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ibm.T.selected_gne_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.527A&#x0003e;T</td><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp176Val</td><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_005476.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005476<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="/protein/NP_005467.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005467<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1714G&#x0003e;C&#x000a0;<sup>1</sup></td><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val572Leu</td></tr><tr><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2135T&#x0003e;C&#x000a0;<sup>1</sup></td><td headers="hd_h_ibm.T.selected_gne_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met712Thr</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="ibm.TF.3.1"><p class="no_margin">See <a href="#ibm.Prevalence">Prevalence</a> for population-specific information.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, <a href="/protein/NP_005467.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005467.1</a>, an isoform of 722 residues, is the key enzyme in the biosynthetic pathway of sialic acid [<a class="bk_pop" href="#ibm.REF.effertz.1999.28771">Effertz et al 1999</a>]. Sialic acids are the most abundant terminal monosaccharides on glycoconjugates of eukaryotic cells. Sialic acids influence adhesion processes, which play an important role in many cellular functions including cell migration, transformation of tissues, inflammation, wound healing, and metastasis. The first step of sialic acid biosynthesis is the formation of ManNAc from UDPGlcNAc with the simultaneous release of UDP. ManNAc is then phosphorylated by a specific kinase. These two steps are synthesized by the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase [<a class="bk_pop" href="#ibm.REF.effertz.1999.28771">Effertz et al 1999</a>], which is highly conserved among mammalian species. In the following steps, sialic acid is formed by condensation of ManNAc-6-phosphate and phosphoenolpyruvate and activated by CTP to form CMP-sialic acid. This nucleotide sugar is finally used as a substrate of sialyltransferases in glycoconjugate biosynthesis [<a class="bk_pop" href="#ibm.REF.penner.2006.2968">Penner et al 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants at the allosteric site of the epimerase abolish the feedback inhibition by CMP-sialic acid, resulting in overproduction of sialic acid and leading to the childhood disease sialuria, an entity distinct from <i>GNE</i>-related myopathy (see <a href="#ibm.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>) [<a class="bk_pop" href="#ibm.REF.seppala.1999.1563">Seppala et al 1999</a>]. At the current time, it is unclear why pathogenic variants in either the epimerase or kinase moiety lead to the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> seen in <i>GNE</i>-related myopathy skeletal muscle (see also discussion in <a href="#ibm.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p>Residual enzyme activity is essential for life; complete lack of enzyme activity as demonstrated by inactivation of <i>GNE</i> in mice is lethal in early embryonic stages [<a class="bk_pop" href="#ibm.REF.schwarzkopf.2002.5267">Schwarzkopf et al 2002</a>]. The crystal structure of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase has recently been solved [<a class="bk_pop" href="#ibm.REF.tong.2009.e7165">Tong et al 2009</a>] and should provide insights into the effect of pathogenic variants.</p><p>It is hypothesized that reduced enzymatic activity is responsible for the skeletal muscle <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, although this remains a matter of controversy. Hypoglycosylation of alpha-dystroglycan can lead to neurologic syndromes with prominent involvement of skeletal muscle including Walker-Warburg syndrome (WWS), muscle-eye-brain disease (MEBD), <a href="/books/n/gene/fcmd/">Fukuyama congenital muscular dystrophy</a> (FCMD), <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> muscular dystrophy type 1C (CMD1C), congenital muscular dystrophy type 1D (CMD1D), limb-girdle-muscular dystrophy type 2I (LGMD2I), and limb-girdle-muscular dystrophy type 2K (LGMD2K); thus, it is tempting to speculate that pathogenic variants in <i>GNE</i> would influence the glycosylation status of alpha-dystroglycan or other skeletal muscle proteins. Several laboratories have studied the glycosylation pattern in skeletal muscle and cultured muscle cells from individuals with <i>GNE</i>-related myopathy. Some laboratories have found a reduction of the sialylation status in muscle of individuals with <i>GNE</i>-related myopathy [<a class="bk_pop" href="#ibm.REF.huizing.2004.196">Huizing et al 2004</a>, <a class="bk_pop" href="#ibm.REF.noguchi.2004.11402">Noguchi et al 2004</a>, <a class="bk_pop" href="#ibm.REF.saito.2004.158">Saito et al 2004</a>], while others have not [<a class="bk_pop" href="#ibm.REF.salama.2005.221">Salama et al 2005</a>].</p><p>A mouse model for <i>GNE</i>-related myopathy has been generated by expressing the human <i>GNE</i> disease <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> <a class="figpopup" href="/books/NBK1262/table/ibm.T.selected_gne_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figibmTselectedgnepathogenicvariants" rid-ob="figobibmTselectedgnepathogenicvariants">p.Asp176Val</a> as a transgene on a mouse <i>Gne</i> knockout background [<a class="bk_pop" href="#ibm.REF.malicdan.2007.2669">Malicdan et al 2007</a>]. The myopathology is similar to that seen in humans and demonstrates scattered small angular fibers, inclusion bodies, and accumulation of several aberrant molecules (beta amyloid, beta-amyloid precursor protein, tau, phosphorylated neurofilaments, proteins of the unfolded protein response, and ubiquitin). The mice exhibit marked hyposialylation. Stimulation of sialylation delayed the muscle atrophy and weakness [<a class="bk_pop" href="#ibm.REF.malicdan.2009.690">Malicdan et al 2009</a>].</p><p>A second mouse model for <i>GNE</i>-related myopathy was generated by introduction of the p.Met712Thr kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> into the endogenous mouse <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>Gne</i> [<a class="bk_pop" href="#ibm.REF.galeano.2007.1585">Galeano et al 2007</a>]. Surprisingly, this mouse model did not recapitulate the human muscle disease since the mice died within the first 72 hours of life from renal disease (glomerular podocytopathology). However, it is interesting to note that the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was rescued by administration of an oral sialic acid precursor, thus supporting the hypothesis that the biochemical defect is related to reduced sialylation.</p><p><a class="bk_pop" href="#ibm.REF.broccolini.2008.971">Broccolini et al [2008]</a> found that neprilysin, a metallopeptidase that cleaves beta-amyloid is hyposialylated in <i>GNE</i>-related myopathy and has reduced enzymatic activity when hyposialylated. The authors hypothesize that hyposialylated neprilysin may reduce beta-amyloid clearance and contribute to its accumulation in muscle fibers.</p><p>Data from the proteomic profile of patients with <i>GNE</i>-related myopathy may yield further insights into the pathophysiology. <a class="bk_pop" href="#ibm.REF.sela.2011.e16334">Sela et al [2011]</a> found that proteins involved in ubiquitination, stress response, mitochondrial processes, and cytoskeleton and sarcomere organization may be involved in <i>GNE</i>-related myopathy.</p></div></div><div id="ibm.References"><h2 id="_ibm_References_">References</h2><div id="ibm.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.abubaker.2007.173">Abu-Baker A, Rouleau GA. Oculopharyngeal muscular dystrophy: recent advances in the underdstanding of the molecular pathogenic mechanisms and treatment strategies. <span><span class="ref-journal">Biochim Biophys Acta. </span>2007;<span class="ref-vol">1772</span>:173–85.</span> [<a href="/pubmed/17110089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17110089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.amouri.2005.361">Amouri R, Driss A, Murayama K, Kefi M, Nishino I, Hentati F. Allelic heterogeneity of GNE gene mutation in two Tunisian families with autosomal recessive inclusion body myopathy. <span><span class="ref-journal">Neuromuscul Disord. </span>2005;<span class="ref-vol">15</span>:361–3.</span> [<a href="/pubmed/15833430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15833430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.arai.2002.516">Arai A, Tanaka K, Ikeuchi T, Igarashi S, Kobayashi H, Asaka T, Date H, Saito M, Tanaka H, Kawasaki S, Uyama E, Mizusawa H, Fukuhara N, Tsuji S. A novel mutation in the GNE gene and a linkage disequilibrium in Japanese pedigrees. <span><span class="ref-journal">Ann Neurol. </span>2002;<span class="ref-vol">52</span>:516–9.</span> [<a href="/pubmed/12325084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12325084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.argov.2003.1519">Argov Z, Eisenberg I, Grabov-Nardini G, Sadeh M, Wirguin I, Soffer D, Mitrani-Rosenbaum S. Hereditary inclusion body myopathy: The Middle Eastern genetic cluster. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1519–23.</span> [<a href="/pubmed/12743242" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12743242</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.argov.1998.1925">Argov Z, Sadeh M, Eisenberg I, Karpati G, Mitrani-Rosenbaum S. Facial weakness in hereditary inclusion body myopathies. <span><span class="ref-journal">Neurology. </span>1998;<span class="ref-vol">50</span>:1925–6.</span> [<a href="/pubmed/9633772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9633772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.argov.1984.33">Argov Z, Yarom R. "Rimmed vacuole myopathy" sparing the quadriceps. A unique disorder in Iranian Jews. <span><span class="ref-journal">J Neurol Sci. </span>1984;<span class="ref-vol">64</span>:33–43.</span> [<a href="/pubmed/6737002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6737002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.borg.1991.102">Borg K, Tome FM, Edstrom L. Intranuclear and cytoplasmic filamentous inclusions in distal myopathy (Welander). <span><span class="ref-journal">Acta Neuropathol (Berl). </span>1991;<span class="ref-vol">82</span>:102–6.</span> [<a href="/pubmed/1656692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1656692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.broccolini.2008.971">Broccolini A, Gidaro T, De Cristofaro R, Morosetti R, Gliubizzi C, Ricci E, Tonali PA, Mirabella M. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle. <span><span class="ref-journal">J Neurochem. </span>2008;<span class="ref-vol">105</span>:971–81.</span> [<a href="/pubmed/18182043" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18182043</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.broccolini.2002.1808">Broccolini A, Pescatori M, D'Amico A, Sabino A, Silvestri G, Ricci E, Servidei S, Tonali PA, Mirabella M. An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1808–9.</span> [<a href="/pubmed/12473780" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12473780</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.broccolini.2004.632">Broccolini A, Ricci E, Cassandrini D, Gliubizzi C, Bruno C, Tonoli E, Silvestri G, Pescatori M, Rodolico C, Sinicropi S, Servidei S, Zara F, Minetti C, Tonali PA, Mirabella M. Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">23</span>:632.</span> [<a href="/pubmed/15146476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15146476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.chai.2011.133">Chai Y, Bertorini TE, McGrew FA. Hereditary inclusion-body myopathy associated with cardiomyopathy: report of two siblings. <span><span class="ref-journal">Muscle Nerve. </span>2011;<span class="ref-vol">43</span>:133–6.</span> [<a href="/pubmed/21082694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21082694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.clarke.1972.247">Clarke JT, Karpati G, Carpenter S, Wolfe LS. The effect of vincristine on skeletal muscle in the rat. A correlative histochemical, ultrastructural and chemical study. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>1972;<span class="ref-vol">31</span>:247–66.</span> [<a href="/pubmed/4112664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4112664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.cole.1988.1025">Cole AJ, Kuzniecky R, Karpati G, Carpenter S, Andermann E, Andermann F. Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome. <span><span class="ref-journal">Brain. </span>1988;<span class="ref-vol">111</span>:1025–37.</span> [<a href="/pubmed/2846114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2846114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.del_bo.2003.113">Del Bo R, Baron P, Prelle A, Serafini M, Moggio M, Fonzo AD, Castagni M, Bresolin N, Comi GP. Novel missense mutation and large deletion of GNE gene in autosomal-recessive inclusion-body myopathy. <span><span class="ref-journal">Muscle Nerve. </span>2003;<span class="ref-vol">28</span>:113–7.</span> [<a href="/pubmed/12811782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12811782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.effertz.1999.28771">Effertz K, Hinderlich S, Reutter W. Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:28771–8.</span> [<a href="/pubmed/10497249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10497249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.eisenberg.2001.83">Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, Barash M, Shemesh M, Sadeh M, Grabov-Nardini G, Shmilevich I, Friedmann A, Karpati G, Bradley WG, Baumbach L, Lancet D, Asher EB, Beckmann JS, Argov Z, Mitrani-Rosenbaum S. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:83–7.</span> [<a href="/pubmed/11528398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11528398</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.eisenberg.2003.99">Eisenberg I, Grabov-Nardini G, Hochner H, Korner M, Sadeh M, Bertorini T, Bushby K, Castellan C, Felice K, Mendell J, Merlini L, Shilling C, Wirguin I, Argov Z, Mitrani-Rosenbaum S. Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps. <span><span class="ref-journal">Hum Mutat. </span>2003;<span class="ref-vol">21</span>:99.</span> [<a href="/pubmed/12497639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12497639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.fukuhara.1980.229">Fukuhara N, Kumamoto T, Tsubaki T. Rimmed vacuoles. <span><span class="ref-journal">Acta Neuropathol (Berl). </span>1980;<span class="ref-vol">51</span>:229–35.</span> [<a href="/pubmed/7445977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7445977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.galeano.2007.1585">Galeano B, Klootwijk R, Manoli I, Sun M, Ciccone C, Darvish D, Starost MF, Zerfas PM, Hoffmann VJ, Hoogstraten-Miller S, Krasnewich DM, Gahl WA, Huizing M. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. <span><span class="ref-journal">J Clin Invest. </span>2007;<span class="ref-vol">117</span>:1585–94.</span> [<a href="/pmc/articles/PMC1878529/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1878529</span></a>] [<a href="/pubmed/17549255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17549255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.griggs.1995.705">Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP. Inclusion body myositis and myopathies. <span><span class="ref-journal">Ann Neurol. </span>1995;<span class="ref-vol">38</span>:705–13.</span> [<a href="/pubmed/7486861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7486861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.hauser.2000.2141">Hauser MA, Horrigan SK, Salmikangas P, Torian UM, Viles KD, Dancel R, Tim RW, Taivainen A, Bartoloni L, Gilchrist JM, Stajich JM, Gaskell PC, Gilbert JR, Vance JM, Pericak-Vance MA, Carpen O, Westbrook CA, Speer MC. Myotilin is mutated in limb girdle muscular dystrophy 1A. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:2141–7.</span> [<a href="/pubmed/10958653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10958653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.huizing.2009.881">Huizing M, Krasnewich DM. Hereditary inclusion body myopathy: a decade of progress. <span><span class="ref-journal">Biochim Biophys Acta. </span>2009;<span class="ref-vol">1792</span>:881–7.</span> [<a href="/pmc/articles/PMC2748147/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2748147</span></a>] [<a href="/pubmed/19596068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19596068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.huizing.2004.196">Huizing M, Rakocevic G, Sparks SE, Mamali I, Shatunov A, Goldfarb L, Krasnewich D, Gahl WA, Dalakas MC. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations. <span><span class="ref-journal">Mol Genet Metab. </span>2004;<span class="ref-vol">81</span>:196–202.</span> [<a href="/pubmed/14972325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14972325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.ideta.1973.579">Ideta T, Shikai T, Uchino M, Okajima T, Akatsuka M. Distal myopathy--evaluation of 4 cases in 2 families. <span><span class="ref-journal">Rinsho Shinkeigaku. </span>1973;<span class="ref-vol">13</span>:579–86.</span> [<a href="/pubmed/4798256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4798256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.karpati.2009.7">Karpati G, O'Ferrall EK. Sporadic inclusion body myositis: pathogenic considerations. <span><span class="ref-journal">Ann Neurol. </span>2009;<span class="ref-vol">65</span>:7–11.</span> [<a href="/pubmed/19194875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19194875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.krause.2003.830">Krause S, Schlotter-Weigel B, Walter MC, Najmabadi H, Wiendl H, M&#x000fc;ller-H&#x000f6;cker J, M&#x000fc;ller-Felber W, Pongratz D, Lochm&#x000fc;ller H. A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation. <span><span class="ref-journal">Neuromuscul Disord. </span>2003;<span class="ref-vol">13</span>:830–4.</span> [<a href="/pubmed/14678807" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14678807</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.lindberg.1991.76">Lindberg C, Borg K, Edstrom L, Hedstrom A, Oldfors A. Inclusion body myositis and Welander distal myopathy: a clinical, neurophysiological and morphological comparison. <span><span class="ref-journal">J Neurol Sci. </span>1991;<span class="ref-vol">103</span>:76–81.</span> [<a href="/pubmed/1650819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1650819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.macdonald.1970.479">Macdonald RD, Engel AG. Experimental chloroquine myopathy. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>1970;<span class="ref-vol">29</span>:479–99.</span> [<a href="/pubmed/4247107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4247107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.malicdan.2009.690">Malicdan MC, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. <span><span class="ref-journal">Nat Med. </span>2009;<span class="ref-vol">15</span>:690–5.</span> [<a href="/pubmed/19448634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19448634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.malicdan.2007.2669">Malicdan MC, Noguchi S, Nonaka I, Hayashi YK, Nishino I. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:2669–82.</span> [<a href="/pubmed/17704511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17704511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.markesbery.1977.727">Markesbery WR, Griggs RC, Herr B. Distal myopathy: electron microscopic and histochemical studies. <span><span class="ref-journal">Neurology. </span>1977;<span class="ref-vol">27</span>:727–35.</span> [<a href="/pubmed/196233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 196233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.martinsson.2000.14614">Martinsson T, Oldfors A, Darin N, Berg K, Tajsharghi H, Kyllerman M, Wahlstrom J. Autosomal dominant myopathy: missense mutation (Glu-706 --&#x0003e; Lys) in the myosin heavy chain IIa gene. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:14614–9.</span> [<a href="/pmc/articles/PMC18967/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC18967</span></a>] [<a href="/pubmed/11114175" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11114175</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.mizusawa.1987.129">Mizusawa H, Kurisaki H, Takatsu M, Inoue K, Mannen T, Toyokura Y, Nakanishi T. Rimmed vacuolar distal myopathy: a clinical, electrophysiological, histopathological and computed tomographic study of seven cases. <span><span class="ref-journal">J Neurol. </span>1987;<span class="ref-vol">234</span>:129–36.</span> [<a href="/pubmed/3585419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3585419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.moriyoshimura.2012.100">Mori-Yoshimura M, Monma K, Suzuki N, Aoki M, Kumamoto T, Tanaka K, Tomimitsu H, Nakano S, Sonoo M, Shimizu J, Sugie K, Nakamura H, Oya Y, Hayashi YK, Malicdan MC, Noguchi S, Murata M, Nishino I. Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations. <span><span class="ref-journal">J Neurol Sci. </span>2012;<span class="ref-vol">318</span>:100–5.</span> [<a href="/pubmed/22507750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22507750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.nemunaitis.2011.1331">Nemunaitis G, Jay CM, Maples PB, Gahl WA, Huizing M, Yardeni T, Tong AW, Phadke AP, Pappen BO, Bedell C, Allen H, Hernandez C, Templeton NS, Kuhn J, Senzer N, Nemunaitis J. Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. <span><span class="ref-journal">Hum Gene Ther. </span>2011;<span class="ref-vol">22</span>:1331–41.</span> [<a href="/pmc/articles/PMC3225042/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3225042</span></a>] [<a href="/pubmed/21517694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21517694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.nemunaitis.2010.403">Nemunaitis G, Maples PB, Jay C, Gahl WA, Huizing M, Poling J, Tong AW, Phadke AP, Pappen BO, Bedell C, Templeton NS, Kuhn J, Senzer N, Nemunaitis J. Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy. <span><span class="ref-journal">J Gene Med. </span>2010;<span class="ref-vol">12</span>:403–12.</span> [<a href="/pubmed/20440751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20440751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.nishino.2002.1689">Nishino I, Noguchi S, Murayama K, Driss A, Sugie K, Oya Y, Nagata T, Chida K, Takahashi T, Takusa Y, Ohi T, Nishimiya J, Sunohara N, Ciafaloni E, Kawai M, Aoki M, Nonaka I. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">59</span>:1689–93.</span> [<a href="/pubmed/12473753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12473753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.noguchi.2004.11402">Noguchi S, Keira Y, Murayama K, Ogawa M, Fujita M, Kawahara G, Oya Y, Imazawa M, Goto Y, Hayashi YK, Nonaka I, Nishino I. Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:11402–7.</span> [<a href="/pubmed/14707127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14707127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.nonaka.1981.141">Nonaka I, Sunohara N, Ishiura S, Satoyoshi E. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. <span><span class="ref-journal">J Neurol Sci. </span>1981;<span class="ref-vol">51</span>:141–55.</span> [<a href="/pubmed/7252518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7252518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.penner.2006.2968">Penner J, Mantey LR, Elgavish S, Ghaderi D, Cirak S, Berger M, Krause S, Lucka L, Voit T, Mitrani-Rosenbaum S, Hinderlich S. Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy. <span><span class="ref-journal">Biochemistry. </span>2006;<span class="ref-vol">45</span>:2968–77.</span> [<a href="/pubmed/16503651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16503651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.sadeh.1993.217">Sadeh M, Gadoth N, Hadar H, Ben-David E. Vacuolar myopathy sparing the quadriceps. <span><span class="ref-journal">Brain. </span>1993;<span class="ref-vol">116</span>:217–32.</span> [<a href="/pubmed/8453459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8453459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.saito.2004.158">Saito F, Tomimitsu H, Arai K, Nakai S, Kanda T, Shimizu T, Mizusawa H, Matsumura K. A Japanese patient with distal myopathy with rimmed vacuoles: missense mutations in the epimerase domain of the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene accompanied by hyposialylation of skeletal muscle glycoproteins. <span><span class="ref-journal">Neuromuscul Disord. </span>2004;<span class="ref-vol">14</span>:158–61.</span> [<a href="/pubmed/14733963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14733963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.salama.2005.221">Salama I, Hinderlich S, Shlomai Z, Eisenberg I, Krause S, Yarema K, Argov Z, Lochmuller H, Reutter W, Dabby R, Sadeh M, Ben-Bassat H, Mitrani-Rosenbaum S. No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2005;<span class="ref-vol">328</span>:221–6.</span> [<a href="/pubmed/15670773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15670773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.sasaki.1969.627">Sasaki K, Mori H, Takahashi K, Nakamura H. Distal myopathy-report of four cases. <span><span class="ref-journal">Clin Neurol (Tokyo). </span>1969;<span class="ref-vol">9</span>:627–37.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.schwarzkopf.2002.5267">Schwarzkopf M, Knobeloch KP, Rohde E, Hinderlich S, Wiechens N, Lucka L, Horak I, Reutter W, Horstkorte R. Sialylation is essential for early development in mice. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2002;<span class="ref-vol">99</span>:5267–70.</span> [<a href="/pmc/articles/PMC122758/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC122758</span></a>] [<a href="/pubmed/11929971" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11929971</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.sela.2011.e16334">Sela I, Milman Krentsis I, Shlomai Z, Sadeh M, Dabby R, Argov Z, Ben-Bassat H, Mitrani-Rosenbaum S. The proteomic profile of hereditary inclusion body myopathy. <span><span class="ref-journal">PLoS One. </span>2011;<span class="ref-vol">6</span>:e16334.</span> [<a href="/pmc/articles/PMC3031555/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3031555</span></a>] [<a href="/pubmed/21305017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21305017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.seppala.1999.1563">Seppala R, Lehto VP, Gahl WA. Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:1563–9.</span> [<a href="/pmc/articles/PMC1377899/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377899</span></a>] [<a href="/pubmed/10330343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10330343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.sivakumar.1996.977">Sivakumar K, Dalakas MC. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. <span><span class="ref-journal">Neurology. </span>1996;<span class="ref-vol">47</span>:977–84.</span> [<a href="/pubmed/8857730" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8857730</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.sparks.2007.3">Sparks S, Rakocevic G, Joe G, Manoli I, Shrader J, Harris-Love M, Sonies B, Ciccone C, Dorward H, Krasnewich D, Huizing M, Dalakas MC, Gahl WA. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. <span><span class="ref-journal">BMC Neurol. </span>2007;<span class="ref-vol">7</span>:3.</span> [<a href="/pmc/articles/PMC1790898/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1790898</span></a>] [<a href="/pubmed/17261181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17261181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.sunohara.1989.65">Sunohara N, Nonaka I, Kamei N, Satoyoshi E. Distal myopathy with rimmed vacuole formation. A follow-up study. <span><span class="ref-journal">Brain. </span>1989;<span class="ref-vol">112</span>:65–83.</span> [<a href="/pubmed/2645018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2645018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.tomimitsu.2004.1607">Tomimitsu H, Shimizu J, Ishikawa K, Ohkoshi N, Kanazawa I, Mizusawa H. Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:1607–10.</span> [<a href="/pubmed/15136692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15136692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.tong.2009.e7165">Tong Y, Tempel W, Nedyalkova L, Mackenzie F, Park HW. Crystal structure of the N-acetylmannosamine kinase domain of GNE. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e7165.</span> [<a href="/pmc/articles/PMC2742894/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2742894</span></a>] [<a href="/pubmed/19841673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19841673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.udd.2001.561">Udd B, Griggs R. Distal myopathies. <span><span class="ref-journal">Curr Opin Neurol. </span>2001;<span class="ref-vol">14</span>:561–6.</span> [<a href="/pubmed/11562566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11562566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.udd.1993.604">Udd B, Partanen J, Halonen P, Falck B, Hakamies L, Heikkil&#x000e4; H, Ingo S, Kalimo H, K&#x000e4;&#x000e4;ri&#x000e4;inen H, Laulumaa V, Palj&#x000e4;rvi L, Rapola J, Reunanen M, Sonninen V, Somer H. Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients. <span><span class="ref-journal">Arch Neurol. </span>1993;<span class="ref-vol">50</span>:604–8.</span> [<a href="/pubmed/8503797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8503797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.udd.2005.636">Udd B, Vihola A, Sarparanta J, Richard I, Hackman P. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:636–42.</span> [<a href="/pubmed/15728284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15728284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.weihl.2011.102">Weihl CC, Miller SE, Zaidman CM, Pestronk A, Baloh RH, Al-Lozi M. Novel GNE mutations in two phenotypically distinct HIBM2 patients. <span><span class="ref-journal">Neuromuscul Disord. </span>2011;<span class="ref-vol">21</span>:102–5.</span> [<a href="/pmc/articles/PMC3030125/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3030125</span></a>] [<a href="/pubmed/21131200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21131200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="ibm.REF.yabe.2003.384">Yabe I, Higashi T, Kikuchi S, Sasaki H, Fukazawa T, Yoshida K, Tashiro K. GNE mutations causing distal myopathy with rimmed vacuoles with inflammation. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:384–6.</span> [<a href="/pubmed/12913203" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12913203</span></a>]</div></li></ul></div></div><div id="ibm.Chapter_Notes"><h2 id="_ibm_Chapter_Notes_">Chapter Notes</h2><div id="ibm.Author_Notes"><h3>Author Notes</h3><p>George Karpati, MD was a distinguished physician and scientist. A Hungarian-born Holocaust survivor, he became a leading expert in muscular dystrophy and other neuromuscular disorders; he held the IW Killam Chair and was Professor of Neurology and Neurosurgery at McGill University. Dr. Karpati died suddenly on February 6, 2009. He leaves behind family and many close friends in Canada, the United States, Israel, and Hungary.</p></div><div id="ibm.Acknowledgments"><h3>Acknowledgments</h3><p>This study was supported by the Canadian Institutes of Health Research, the Muscular Dystrophy Association of Canada and USA, the Association Fran&#x000e7;aise contre les Myopathies, the Geneva University Hospital, and the Lichtensteinstiftung, Basel, Switzerland.</p></div><div id="ibm.Author_History"><h3>Author History</h3><p>Erin O'Ferrall, MD, MSc, FRCPC (2009-present)<br />George Karpati, MD, FRCP(C), FRS(C), OC; McGill University (2004-2009)<br />Michael Sinnreich, MD, PhD (2004-present)</p></div><div id="ibm.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 March 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 August 2009 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 May 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 March 2004 (me) Review posted live</div></li><li class="half_rhythm"><div>17 November 2003 (gk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1262</span><span class="label">PMID: <a href="/pubmed/20301439" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301439</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/glyt1-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/ml2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1262&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1262/?report=reader">PubReader</a></li><li><a href="/books/NBK1262/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1262" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1262" style="display:none" title="Cite this Page"><div class="bk_tt">O'Ferrall EK, Sinnreich M. GNE-Related Myopathy. 2004 Mar 26 [Updated 2013 Mar 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1262/pdf/Bookshelf_NBK1262.pdf">PDF version of this page</a> (471K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ibm.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#ibm.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#ibm.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#ibm.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#ibm.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#ibm.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#ibm.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#ibm.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#ibm.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#ibm.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#ibm.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10020[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GNE</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1262+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1493238" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1493238" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1493238" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1493238" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/12473753" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy.</a><span class="source">[Neurology. 2002]</span><div class="brieflinkpop offscreen_noflow">Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nishino I, Noguchi S, Murayama K, Driss A, Sugie K, Oya Y, Nagata T, Chida K, Takahashi T, Takusa Y, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neurology. 2002 Dec 10; 59(11):1689-93. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26546927" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [GNE myopathy].</a><span class="source">[Med Sci (Paris). 2015]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [GNE myopathy].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Urtizberea JA, Béhin A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Med Sci (Paris). 2015 Nov; 31 Spec No 3:20-7. Epub 2015 Nov 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24707269" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Novel Mutation of the GNE Gene in Distal Myopathy with Rimmed Vacuoles: A Case with Inflammation.</a><span class="source">[Case Rep Neurol. 2014]</span><div class="brieflinkpop offscreen_noflow">A Novel Mutation of the GNE Gene in Distal Myopathy with Rimmed Vacuoles: A Case with Inflammation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tanboon J, Rongsa K, Pithukpakorn M, Boonyapisit K, Limwongse C, Sangruchi T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Case Rep Neurol. 2014 Jan; 6(1):55-9. Epub 2014 Mar 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17704511" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.</a><span class="source">[Hum Mol Genet. 2007]</span><div class="brieflinkpop offscreen_noflow">A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Malicdan MC, Noguchi S, Nonaka I, Hayashi YK, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mol Genet. 2007 Nov 15; 16(22):2669-82. Epub 2007 Aug 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/15676110" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy.</a><span class="source">[Curr Neurol Neurosci Rep. 2005]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Distal myopathy with rimmed vacuoles and hereditary inclusion body myopathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nonaka I, Noguchi S, Nishino I. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Curr Neurol Neurosci Rep. 2005 Feb; 5(1):61-5. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301439" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301439" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040e4a75f66d18aaa8b75b">GNE-Related Myopathy - GeneReviews®</a><div class="ralinkpop offscreen_noflow">GNE-Related Myopathy - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:35:06-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B7DF5E040E02100000000001E0009&amp;ncbi_session=CE8B7DF5E040E491_0030SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1262%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1262&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1262/&amp;ncbi_pagename=GNE-Related Myopathy - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B7DF5E040E491_0030SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>